Larimar director buys 8,000 shares after 16% weekly gain
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
A director at Larimar Therapeutics, Frank E. Thomas, recently purchased 8,000 shares of company stock for $21,800. This insider transaction follows a 16% gain in the stock over the past week, with analysis suggesting the stock is undervalued. The company also recently appointed John B. Harlow, Jr. as president and COO, and Wedbush reiterated an Outperform rating with an Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context